7341 - 7350 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Fox Trial Finder, un nouvel outil pour la recherche cliniqueJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 170Issue #:Start Page: A133End Page: A134Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2014.01.360Citation Count: 0
-
RESTRICTEDTitle: P.19.3 Phenotypic characterization of the autosomal recessive (Pink-1 and DJ-1) gene knockout rat models of Parkinson’s diseaseJournal Name: Neuromuscular DisordersPublisher: Elsevier BVVol: 23Issue #: 9-10Start Page: 836End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nmd.2013.06.684Citation Count: 1
-
OPENTitle: Using Qualitative Methods to Understand Physical Activity and Weight Management Among Bangladeshis in New York City, 2013Journal Name: Preventing Chronic DiseasePublisher: Centers for Disease Control and Prevention - Preventing Chronic DiseaseVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.5888/pcd13.160077Best OA location URL: https://www.cdc.gov/pcd/issues/2016/pdf/16_0077.pdfCitation Count: 20
-
RESTRICTEDTitle: If You Don’t Ask, You Won’t Know: Inclusive Recruitment Strategies for the Parkinson Progression Markers Initiative (PPMI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 122Issue #:Start Page: 106689End Page: 106689Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106689Citation Count: 0
-
OPENTitle: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 PhosphorylationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 157Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/58956Citation Count: 11
-
RESTRICTEDTitle: Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 114Issue #:Start Page: 105511End Page: 105511Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105511Citation Count: 10
-
OPENTitle: The Relationship between p-tau217, p-tau231, and p-tau205 in the Human Brain Is Affected by the Cellular Environment and Alzheimer’s Disease PathologyJournal Name: CellsPublisher: MDPI AGVol: 13Issue #: 4Start Page: 331End Page: 331Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells13040331Best OA location URL: https://www.mdpi.com/2073-4409/13/4/331/pdf?version=1707645473Citation Count: 4
-
OPENTitle: To be or not to be pink(1): contradictory findings in an animal model for Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcz016Best OA location URL: https://academic.oup.com/braincomms/article-pdf/1/1/fcz016/33639299/fcz016.pdfCitation Count: 34
-
RESTRICTEDTitle: P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_21Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.08.089Citation Count: 0
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: http://doi.org/10.1016/j.jalz.2013.12.011Citation Count: 69